Parvo Shield L5E

Manufacturer: Novartis (Farm Animal)

Parvovirus Vaccine

Killed Virus

Erysipelothrix Rhusiopathiae-leptospira Canicola-grippotyphosa-hardjo-icterohaemorrhagiae-pomona Bacterin

For Use In Animals Only

Parvo Shield L5E Indications

For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus, Erysipelothrix rhusiopathiae, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona.

Adjuvant

Aluminum hydroxide.

Directions

Shake well before using. Inject 5 mL intramuscularly to gilts and sows 4-6 weeks prior to breeding. Repeat in 3-4 weeks. Revaccinate with a single dose 4-6 weeks prior to each subsequent breeding. Vaccinate boars semiannually.

Precautions

Store out of direct sunlight at 2°-7° C (35°-45° F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2010 Novartis; Registered trademark of Novartis AG

10 Doses	50 mL	137-02
50 Doses	250 mL	139-03

Nac No.

11140287